ammonium tungsten antimonate hydroxide oxide and tungsten

ammonium tungsten antimonate hydroxide oxide has been researched along with tungsten in 37 studies

Compound Research Comparison

Studies (ammonium tungsten antimonate hydroxide oxide)	Trials (ammonium tungsten antimonate hydroxide oxide)	Recent Studies (post-2010) (ammonium tungsten antimonate hydroxide oxide)	Studies (tungsten)	Trials (tungsten)	Recent Studies (post-2010) (tungsten)
40	2	0	2,869	14	1,059

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	34 (91.89)	18.7374
1990's	3 (8.11)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chermann, JC; Jasmin, C; Sinoussi, FC	1
Chermann, JC; Jasmin, C; Werner, GH	1
Atanasiu, P; Chermann, JC; Jasmin, C; Tsiang, H	1
Inouye, Y; Kunihara, J; Nakamura, S; Nakata, A; Tokutake, Y; Yamase, T; Yoshida, T	1
Hill, CL; Schinazi, RF; Weeks, MS	1
Berry, JP; Galle, P	1
Hirsch, MS; Kaplan, JC	1
Kimberlin, RH; Walker, CA	2
Buimovici-Klein, E; Cooper, LZ; Englard, A; Grieco, MH; Lange, M; McKinley, GF; Ong, KR; Reddy, M	1
Katinka, MD	1
Eliaszewicz, M; Frottier, J; Laporte, JP; Meyohas, MC; Najman, A; Woehrle, R	1
Barre-Sinoussi, F; Chermann, JC; Vittecoq, D; Woerle, R	1
Barré-Sinoussi, F; Chermann, JC; Nakane, H; Ono, K	1
Barre-Sinoussi, FC; Chermann, JC; Daveloose, D; Dormont, D; Lambert, P; Spire, B; Yeramian, P	1
Matthes, E; Reimer, K; Rosenthal, HA; Scholz, D	1
Burgard, M; Descamps, P; Guetard, D; Herson, S; Rouzioux, C; Rozenbaum, W; Sansonetti, P; Vittecoq, D	1
Aymard, JP; Ferry, R; Janot, C; Legras, B; May, T; Schooneman, F; Streiff, F	1
Kaplan, JC; Sandström, EG	1
Chottard, G; Hervé, G; Hervé, M; Michelon, M	1
Broder, S; Yarchoan, R	1
Barre-Sinoussi, F; Chermann, JC; Dormont, D; Gentilini, M; Griscelli, C; Montagnier, L; Rozenbaum, W; Spire, B; Vilmer, E	1
Blancou, J; Bussereau, F; Picard, M; Sureau, P	1
Sandström, E	1
Weber, J	1
Fauci, AS; Lane, HC	1
Marwick, C; Riesenberg, DE	1
Moskovitz, BL	1
Rada, B	1
Castagna, A; Crocchiolo, P; Lazzarin, A; Moroni, M; Orlando, G; Verani, P	1
Blancou, J; Pepin, M	1
Boy-Loustau, C; Chermann, JC; Herve, G; Jasmin, C; Raybaud, N; Raynaud, M; Sinoussi, F; Souchay, P; Teze, A	1
Barré-Sinoussi, F; Chermann, JC; Matsumoto, T; Nakane, H; Ono, K	1
Chermann, JC; Herve, G; Herve, M; Jasmin, C; Sinoussi-Barre, F	1
Chermann, JC; Jasmin, C; Ono, K; Souyri-Caporale, M; Tovey, MG	1
Cibert, C; Jasmin, C	1
Augery, Y; Chermann, JC; Degiorgis, V; Jasmin, C; Larnicol, N; Le Bousse-Kerdiles, C; Teze, A	1

Reviews

6 review(s) available for ammonium tungsten antimonate hydroxide oxide and tungsten

Article	Year
Prospects of therapy for infections with human T-lymphotropic virus type III. Annals of internal medicine, 1985, Volume: 103, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication	1985
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Drugs, 1987, Volume: 34, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1987
Progress in the development of antiviral therapy for HTLV-III-associated diseases. Important advances in oncology, 1987 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1987
Antiviral drugs for AIDS. Current status and future prospects. Drugs, 1986, Volume: 31, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1986
Immunologic reconstitution in the acquired immunodeficiency syndrome. Annals of internal medicine, 1985, Volume: 103, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antimony; Antiviral Agents; Bone Marrow Transplantation; Deltaretrovirus; Humans; Immunotherapy; Interferon Type I; Interferon-gamma; Interleukin-2; Lymphocyte Transfusion; Ribavirin; Suramin; Thymus Gland; Tungsten; Tungsten Compounds	1985
[Experimental chemotherapy of AIDS]. Casopis lekaru ceskych, 1988, May-27, Volume: 127, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1988

Trials

2 trial(s) available for ammonium tungsten antimonate hydroxide oxide and tungsten

Article	Year
Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. AIDS (London, England), 1989, Volume: 3, Issue:10 Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins	1989
Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Aspartate Aminotransferases; Blood Cell Count; Clinical Trials as Topic; Drug Tolerance; Humans; Male; Platelet Count; T-Lymphocytes; Tungsten; Tungsten Compounds	1988

Article

Year

Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.

AIDS (London, England), 1989, Volume: 3, Issue:10

Topics: Antimony; Antiviral Agents; Drug Evaluation; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Leukocyte Count; Platelet Count; Random Allocation; Reverse Transcriptase Inhibitors; Thrombocytopenia; Tungsten; Tungsten Compounds; Viral Core Proteins

1989

Clinical trial of tolerance of HPA-23 in patients with acquired immune deficiency syndrome.

Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:9

Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Aspartate Aminotransferases; Blood Cell Count; Clinical Trials as Topic; Drug Tolerance; Humans; Male; Platelet Count; T-Lymphocytes; Tungsten; Tungsten Compounds

1988

Other Studies

29 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and tungsten

Article	Year
Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate. Biochemical and biophysical research communications, 1975, Aug-18, Volume: 65, Issue:4 Topics: Antimony; DNA-Directed RNA Polymerases; Kinetics; Moloney murine leukemia virus; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Templates, Genetic; Tungsten; Tungsten Compounds	1975
Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice. The Journal of general virology, 1976, Volume: 31, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Blood; Brain; Drug Synergism; Encephalomyocarditis virus; Enterovirus Infections; Female; Injections, Intraperitoneal; Interferons; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Tungsten; Tungsten Compounds; Vesicular stomatitis Indiana virus; Virus Diseases; Virus Replication	1976
Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. The Journal of general virology, 1978, Volume: 40, Issue:3 Topics: Antimony; Antiviral Agents; Dose-Response Relationship, Drug; Rabies virus; Tungsten; Tungsten Compounds; Viral Plaque Assay	1978
Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase. Chemical & pharmaceutical bulletin, 1992, Volume: 40, Issue:3 Topics: Antimony; Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; HIV-1; Humans; Polymers; Reverse Transcriptase Inhibitors; Tungsten; Tungsten Compounds	1992
Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates. Journal of medicinal chemistry, 1990, Volume: 33, Issue:10 Topics: Antimony; Antiviral Agents; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; HIV; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Magnetic Resonance Spectroscopy; Structure-Activity Relationship; Tungsten; Tungsten Compounds	1990
Subcellular localization of HPA-23 in different rat organs: electron microprobe study. Experimental and molecular pathology, 1990, Volume: 53, Issue:3 Topics: Animals; Antimony; Antiviral Agents; Dose-Response Relationship, Drug; Electron Probe Microanalysis; Rats; Tissue Distribution; Tungsten; Tungsten Compounds	1990
Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:3 Topics: Animals; Antimony; Carrageenan; Dextran Sulfate; Dextrans; Female; Mice; Molecular Weight; Scrapie; Tungsten; Tungsten Compounds	1986
Reverse transcriptase activity (RTA) in lymphocyte cultures of AIDS patients treated with HPA-23. AIDS research, 1986,Fall, Volume: 2, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Antimony; Antiviral Agents; Drug Evaluation; Humans; Lymphocytes; Male; Middle Aged; RNA-Directed DNA Polymerase; Tungsten; Tungsten Compounds	1986
RNA-dependent DNA polymerase activity in Paramecium tetraurelia: what for? European journal of biochemistry, 1987, Mar-16, Volume: 163, Issue:3 Topics: Animals; Antimony; Avian Myeloblastosis Virus; Cell Cycle; Centrifugation, Density Gradient; Dose-Response Relationship, Drug; Ethidium; Foscarnet; Magnesium; Manganese; Paramecium; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Suramin; Templates, Genetic; Tungsten; Tungsten Compounds	1987
[Addition of HPA 23 to cyclosporin in the treatment of thrombopenic purpura in HIV-positive subjects]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2 Topics: Adult; Antimony; Cyclosporins; Drug Therapy, Combination; HIV Seropositivity; Humans; Male; Purpura, Thrombocytopenic; Reverse Transcriptase Inhibitors; Tungsten; Tungsten Compounds	1987
Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1988, Volume: 42, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Cells, Cultured; Half-Life; Humans; Lymphocytes; RNA-Directed DNA Polymerase; Thrombocytopenia; Time Factors; Tungsten; Tungsten Compounds	1988
Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23). European journal of biochemistry, 1988, Sep-15, Volume: 176, Issue:2 Topics: Animals; Antimony; Antiviral Agents; Cell Line; DNA Polymerase I; DNA Polymerase II; DNA Polymerase III; HIV; Humans; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Tungsten; Tungsten Compounds	1988
Cellular and molecular mechanisms of antiretroviral effects of HPA23. Cancer detection and prevention, 1988, Volume: 12, Issue:1-6 Topics: Antimony; Antiviral Agents; Cell Fractionation; Electron Spin Resonance Spectroscopy; HIV; Humans; Kinetics; Lymphocytes; Microscopy, Electron; Reverse Transcriptase Inhibitors; Spectrophotometry; Tungsten; Tungsten Compounds; Virus Replication	1988
Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus. Acta virologica, 1989, Volume: 33, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Cattle; Kinetics; Leukemia Virus, Bovine; Models, Biological; Retroviridae; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Suramin; Tungsten; Tungsten Compounds; Zidovudine	1989
Toxicity of HPA-23 (ammonium-21-tungsto-9-antimoniate) for normal human myeloid progenitor cells (GM-CFU) in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1989, Volume: 43, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Antimony; Antiviral Agents; Child; Dose-Response Relationship, Drug; Female; Granulocytes; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Tungsten; Tungsten Compounds	1989
Modification of the structural and redox properties of cytochrome c by heteropolytungstate binding. Biochimica et biophysica acta, 1987, Dec-18, Volume: 916, Issue:3 Topics: Animals; Antimony; Arsenic; Cytochrome c Group; Electron Spin Resonance Spectroscopy; Horses; Hydrogen-Ion Concentration; Oxidation-Reduction; Potentiometry; Silicon; Tungsten; Tungsten Compounds	1987
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (London, England), 1985, Feb-23, Volume: 1, Issue:8426 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antimony; Deltaretrovirus; Female; Humans; Male; Tungsten; Tungsten Compounds	1985
Treatment of rabies in mice and foxes with antiviral compounds. Acta virologica, 1988, Volume: 32, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Drug Evaluation, Preclinical; Foxes; Injections, Intramuscular; Injections, Intraventricular; Male; Mice; Rabies; Time Factors; Tungsten; Tungsten Compounds	1988
AIDS: the virus, antivirals and vaccines. British journal of hospital medicine, 1987, Volume: 37, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine	1987
Anti-AIDS agents show varying early results in vitro and in vivo. JAMA, 1985, Nov-08, Volume: 254, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1985
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antimony; Antiviral Agents; Humans; Interferon Type I; Ribavirin; Ribonucleosides; Tungsten; Tungsten Compounds	1987
Ammonium-5-tungsto-2-antimoniate (HPA23) can prevent fox rabies. Archives of virology, 1985, Volume: 83, Issue:3-4 Topics: Animals; Antimony; Antiviral Agents; Foxes; Lethal Dose 50; Rabies; Tungsten; Tungsten Compounds	1985
In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate. Journal of the National Cancer Institute, 1974, Volume: 53, Issue:2 Topics: Animals; Antigens, Viral; Antimony; Antiviral Agents; Friend murine leukemia virus; Gammaretrovirus; Immunization; Interferon Inducers; Leukemia L1210; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Moloney murine leukemia virus; Sarcoma; Sarcoma, Experimental; Splenomegaly; Tungsten; Tungsten Compounds	1974
Inhibition of DNA polymerase alpha activity by ammonium 21-tungsto-9-antimoniate (HPA23). Nucleic acids symposium series, 1984, Issue:15 Topics: Animals; Antimony; Antiviral Agents; Burkitt Lymphoma; Cell Line; DNA Polymerase I; DNA Polymerase II; Herpesvirus 4, Human; Humans; Kinetics; Mice; Plasmacytoma; Tungsten; Tungsten Compounds	1984
Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases. Biochemical and biophysical research communications, 1983, Oct-14, Volume: 116, Issue:1 Topics: Antimony; Arsenates; DNA-Directed RNA Polymerases; Escherichia coli; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Substrate Specificity; Tungsten; Tungsten Compounds	1983
Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine. The Journal of general virology, 1984, Volume: 65 ( Pt 4) Topics: Antigens, Viral; Antimony; Cell Line; DNA; DNA Polymerase II; DNA-Directed DNA Polymerase; Herpesvirus 4, Human; Humans; Idoxuridine; Interphase; Time Factors; Tungsten; Tungsten Compounds; Virus Activation	1984
The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Archives of virology, 1983, Volume: 78, Issue:1-2 Topics: Animals; Antimony; Antiviral Agents; Cricetinae; Female; Mesocricetus; Mice; Scrapie; Sheep; Tungsten; Tungsten Compounds	1983
Determination of the intracellular localization of a polyoxotungstate (HPA-23) by Raman Laser and X fluorescence spectroscopies. Biochemical and biophysical research communications, 1982, Oct-29, Volume: 108, Issue:4 Topics: Animals; Antimony; Cells, Cultured; Electron Probe Microanalysis; Fibroblasts; Mice; Mice, Inbred C3H; Microscopy, Fluorescence; Spectrum Analysis, Raman; Tungsten; Tungsten Compounds	1982
In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia. The Journal of general virology, 1981, Volume: 55, Issue:Pt 1 Topics: Animals; Antimony; Antiviral Agents; Erythropoiesis; Friend murine leukemia virus; Leukemia, Experimental; Mice; Splenomegaly; Time Factors; Tungsten; Tungsten Compounds	1981